Sunday, June 14, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 254 of 1,261

  1. US 11376313

    Cancer treatment

    Propanc Pty Ltd · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted

  2. US 11377659

    Short hairpin RNA (shRNA734) and use of same to positively select and eliminate genetically modified cells

    THE REGENTS OF THE UNIVERSITY OE CALIFORNIA · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted

  3. US 11377502

    Anti-MSR1 antibodies and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted

  4. US 11377643

    Therapeutics for glycogen storage disease type III

    Ultragenyx Pharmaceutical Inc. · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted

  5. US 11377469

    CD73 inhibitors

    ORIC PHARMACEUTICALS, INC. · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted

  6. US 11377468

    Antimicrobial compounds, compositions, and uses thereof

    Lakewood Amedex, Inc. · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted

  7. US 11377450

    Functionalized heterocycles as antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted

  8. US 11377447

    Targeted therapeutics

    Madrigal Pharmaceuticals, Inc. · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted

  9. US 11377444

    Pyridopyrimidine compounds acting as mTORC 1/2 dual inhibitors

    Medshine Discovery Inc. · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted

  10. US 11377451

    Compositions and methods for treating cancer

    The Regents of the University of California · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted

  11. US 11376324

    Sting activating nanovaccine for immunotherapy

    The Board of Regents of the University of Texas System · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted

  12. US 11377421

    Psychotropic agents and uses thereof

    LB PHARMACEUTICALS INC. · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted

  13. US 11376405

    Therapeutic agent preparations into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted

  14. US 11376404

    Drug releasing coatings for medical devices

    Lutonix, Inc. · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted

  15. US 11376263

    Cyproterone acetate compositions and uses thereof

    Fortress Biotech, Inc. · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted

  16. US 11376228

    Polysubstituted benzene, preparation method thereof, and method of using the same

    South China University of Technology · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted

  17. US 11376311

    Methods of treating microbial infection and inflammation

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted

  18. US 11376303

    Compositions and methods for treating nervous system injuries

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted

  19. US 11376226

    Biodegradable polymer microparticle containing steroid drug and preparation method therefor

    REGENBiotech, Inc. · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted

  20. US 11376225

    Composite flash-precipitated nanoparticles

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted

  21. US 11376221

    Polymer particles for neutrophil injury

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 5, 2022 · Expires Jun 30, 2042

    granted

  22. CA 3202908

    ANTAGONISTE D'INTEGRINES ALPHA-V BETA-3 ET/OU ALPHA-V BETA-5 RADIOMARQUE DESTINE A ETRE UTILISE EN TANT QU'AGENT THERAGNOSTIQUE

    ADVANCED ACCELERATOR APPLICATIONS INT SA [CH] · Granted Jun 30, 2022 · Expires Jun 25, 2042

    granted

  23. US 11370808

    Pyrazole compounds and methods for making and using the compounds

    Rigel Pharmaceuticals, Inc. · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted

  24. US 11369627

    Myrtle polysaccharide P1, the separation method thereof and the use in preparing hypolipidemic drugs therefor

    South China Normal University School of Life Sciences · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.